Calcium enables Annexin V to bind exposed phosphatidylserine on the cell surface. Without this calcium-dependent interaction, the protein cannot reliably report the membrane change associated with apoptosis. This requirement connects the probe’s biochemical behavior to assay conditions, so fluorescence should be interpreted within a calcium-supported staining system.
During apoptosis, phosphatidylserine shifts from the inner leaflet of the plasma membrane to the outer surface. Annexin V detects this redistribution rather than merely measuring whether a cell is present or intact. The resulting signal identifies a membrane-associated change linked to apoptosis, while viability-dye information helps classify the broader cell population.
A membrane-impermeant viability dye provides a second measurement alongside phosphatidylserine binding. Combining the two signals helps distinguish viable cells from cells showing apoptotic membrane changes and from necrotic populations. This paired strategy is more informative than relying on Annexin V fluorescence alone because it relates phosphatidylserine exposure to cell viability status.
The workflow uses fluorescently labeled Annexin V together with a membrane-impermeant viability dye, followed by analysis through flow cytometry or microscopy. Calcium must be present so Annexin V can bind exposed phosphatidylserine. The resulting fluorescence measurements are then used to compare cell populations according to membrane changes and viability.
Both flow cytometry and microscopy can analyze fluorescent Annexin V labeling, but they provide different ways to examine the stained material. Flow cytometry supports assessment of viable, apoptotic, and necrotic cell populations, whereas microscopy allows the labeled cells to be examined through an imaging-based readout. The choice depends on the experimental purpose.
Annexin V measurements support studies that need to track cell-death-associated membrane changes. Applications include developmental biology, disease mechanisms, toxicology, and drug evaluation. In these settings, combining phosphatidylserine detection with viability information helps researchers examine how biological conditions or treatments relate to apoptotic and necrotic cell populations.